يعرض 1 - 10 نتائج من 17 نتيجة بحث عن '"biological drugs"', وقت الاستعلام: 1.38s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    المصدر: Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Dalsgaard Pedersen, D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Hetland, M L 2020, ' Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci ', Annals of the Rheumatic Diseases, vol. 79, no. 2, e14 . https://doi.org/10.1136/annrheumdis-2018-214788Test
    Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Dalsgaard Pedersen, D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Hetland, M L 2020, ' Response to : 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB 4 : Possible fallout on non-medical switching' by Cantini and Benucci ', Annals of the Rheumatic Diseases, vol. 79, no. 2, e14 . https://doi.org/10.1136/annrheumdis-2018-214788Test
    Glintborg, B, Loft, A G, Omerovic, E, Hendricks, O, Linauskas, A, Espesen, J, Danebod, K, Jensen, D V, Nordin, H, Dalgaard, E B, Chrysidis, S, Kristensen, S, Raun, J L, Lindegaard, H, Manilo, N, Jakobsen, S H, Hansen, I M J, Dalsgaard Pedersen, D, Sørensen, I J, Andersen, L S, Grydehøj, J, Mehnert, F, Krogh, N S & Hetland, M L 2020, ' Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci ', Annals of the Rheumatic Diseases, vol. 79, no. 2, pp. e14 . https://doi.org/10.1136/annrheumdis-2018-214788Test

  6. 6
  7. 7
  8. 8
  9. 9
  10. 10